25
Views
16
CrossRef citations to date
0
Altmetric
Research Article

The Use of Betamethasone and Hyaluronidase Injections in the Treatment of Peyronie?s Disease

, &
Pages 355-360 | Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Gianni Paulis, Andrea Paulis, Gennaro Romano, Davide Barletta & Andrea Fabiani. (2017) Rationale of combination therapy with antioxidants in medical management of Peyronie’s disease: results of clinical application. Research and Reports in Urology 9, pages 129-139.
Read now
Gianni Paulis, Davide Barletta, Paolo Turchi, Antonio Vitarelli, Giuseppe Dachille, Andrea Fabiani & Romano Gennaro. (2016) Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie’s disease: a case-control study. Research and Reports in Urology 8, pages 1-10.
Read now
Ibrahim A Abdel-Hamid & Tarek Anis. (2011) Peyronie's disease: perspectives on therapeutic targets. Expert Opinion on Therapeutic Targets 15:8, pages 913-929.
Read now

Articles from other publishers (13)

Giorgio Ivan Russo, Christian Di Gaetano, Alberto Costa Silva & Afonso Morgado. 2022. Andrology and Sexual Medicine. Andrology and Sexual Medicine 117 150 .
Fuxun Zhang, Feng Qin & Jiuhong Yuan. (2021) Molecular Mechanisms and Current Pharmacotherapy of Peyronie’s Disease: A Review. Frontiers in Pharmacology 12.
Crossref
U. Milenkovic & M. Albersen. 2020. Peyronie's Disease: Pathophysiology and Treatment. Peyronie's Disease: Pathophysiology and Treatment 91 103 .
Peter Tsambarlis & Laurence A. Levine. (2018) Nonsurgical management of Peyronie’s disease. Nature Reviews Urology 16:3, pages 172-186.
Crossref
Giorgio Ivan Russo, Uros Milenkovic, Wayne Hellstrom, Laurence A. Levine, David Ralph & Maarten Albersen. (2018) Clinical Efficacy of Injection and Mechanical Therapy for Peyronie's Disease: A Systematic Review of the Literature. European Urology 74:6, pages 767-781.
Crossref
Gianni Paulis. 2015. Peyronie’s Disease. Peyronie’s Disease 97 105 .
Johannes Wohlrab, David Wohlrab, Lukas Wohlrab, Christiane Wohlrab & Angelika Wohlrab. (2014) Use of Hyaluronidase for Pharmacokinetic Increase in Bioavailability of Intracutaneously Applied Substances. Skin Pharmacology and Physiology 27:5, pages 276-282.
Crossref
Carlo Pavone, Giancarlo Napoli, Giovanni Caruana, Vincenza Alonge, Manuela Usala & Daniela Abbadessa. (2011) Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study. BJU International 110:1, pages 117-121.
Crossref
Carlo Pavone, Carlo Melloni, Irina Oxenius, Giancarlo Napoli, Manuela Usala & Daniela Abbadessa. (2018) Safety and Tolerability of Local Treatment with Iloprost in Patients with Peyronie's Disease. A Phase 1 Pilot Study and Proposal of a new Symptom Questionnaire. Urologia Journal 77:3, pages 172-179.
Crossref
B Fallon. (2007) ‘Off-label’ drug use in sexual medicine treatment. International Journal of Impotence Research 20:2, pages 127-134.
Crossref
Shane Russell, William Steers & Kevin T. McVary. (2007) Systematic Evidence-Based Analysis of Plaque Injection Therapy for Peyronie's Disease. European Urology 51:3, pages 640-647.
Crossref
Yemi Akin-Olugbade & John P Mulhall. (2007) The medical management of Peyronie's disease. Nature Clinical Practice Urology 4:2, pages 95-103.
Crossref
Garrett H. Lischer & Ajay Nehra. (2001) New advances in Peyronieʼs disease. Current Opinion in Urology 11:6, pages 631-636.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.